Genedata Biologics 1.5 simplifies data exchange by providing a collaboration platform for pharmaceutical, biotechnology, and technology companies, contract research organizations (CROs) and academic networks.
The platform helps to exchange raw and result data with standardized data exchange formats for molecule data, sequence data, assay data, and other data types.
Genedata Biologics as an integrated data management platform enables registration and documentation of externally-generated materials and samples such as proteins, DNA and cell lines, including antigen materials, plasmid batches, and antibody libraries.
Genedata Biologics also provides the infrastructure for implementation of corporate-specific workflows and technologies such as proprietary molecule formats, proprietary antibody libraries and display systems, or corporate identifiers.
Genedata CEO Othmar Pfannes said it focuses on providing a complete biologics platform that covers the R&D process from antibody screening to protein engineering and production.